Methylene blue is a long-established compound with an FDA-approved use for methemoglobinemia, more recently discussed in biohacking circles for mitochondrial and cognitive-support research. It carries a well-documented interaction risk with serotonergic medications.
Benefits
Methylene blue is one of the oldest synthetic drugs still in clinical use, FDA-approved for treating methemoglobinemia (a blood disorder where hemoglobin can't release oxygen properly). Research interest in this space centers on its effects on mitochondrial electron transport and possible cognitive/neuroprotective effects at low doses — this specific angle needs its own dedicated citation pass beyond what's covered here, given the compound's long and complex pharmacology.
The most important safety fact for this compound
Methylene blue is a potent, reversible MAO-A inhibitor — clinically significant monoamine oxidase inhibition can occur even at low doses (under 1mg/kg). The FDA issued a safety warning in July 2011 specifically about serotonin syndrome risk when methylene blue is combined with serotonergic medications (SSRIs, SNRIs, tricyclic antidepressants, triptans, tramadol, meperidine). At least 14 published case reports document probable or definite serotonin toxicity from this combination, including at least one fatality. The FDA's own recommendation: if methylene blue must be given to someone on a serotonergic drug, discontinue the serotonergic drug first, use the lowest possible methylene blue dose, and monitor for CNS effects. (This is a documented FDA warning, not a theoretical/mechanism-based caution like several other findings in this research batch — treat it accordingly on the page.)
Dosage
Dosing varies significantly by intended use (methemoglobinemia treatment vs. other research applications) — a specific dose wasn't the focus of this research pass. What's unambiguous is the drug-interaction warning above, which applies regardless of the specific dose or use case.
Is Methylene Blue FDA-approved?+
Yes, for treating methemoglobinemia, a specific blood disorder. Biohacking use for cognitive or mitochondrial support falls outside that approved indication.
What is the main safety concern with Methylene Blue?+
It can interact with serotonergic drugs (including many antidepressants) to cause serotonin syndrome, a serious and well-documented risk that anyone considering it should be aware of.
What is Methylene Blue researched for outside its approved use?+
Mitochondrial function and cognitive-support research is the most common theme in current biohacking discussion.
Why are people suddenly talking about Methylene Blue as a nootropic?+
It's one of the oldest synthetic drugs in existence — first made in 1876, FDA-approved for over a century for methemoglobinemia. The nootropic interest is newer: it acts as an alternative electron carrier in your mitochondria, potentially helping cells produce ATP more efficiently, the mechanism behind the energy/focus claims.
Does it actually turn your urine blue?+
Yes, this one's completely real and harmless — a well-known, expected side effect, not a sign anything's wrong.
Looking for something specific, or placing a wholesale order? Send us a DM or email.